EP2865422

Alfa-MSH afleiður í meðferð við ljóshúðkvilla

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    31.8.2007
  • EP published:
    18.10.2017
  • EP application number:
    14173509.2
  • Max expiry date:
    30.8.2027
  • Title:
    Alpha-MSH derivatives for the treatment of photodermatoses

Timeline

Today
31.8.2007EP application
18.10.2017EP Publication
1.11.2017Translation submitted
15.11.2017Registration published

Owner

  • Name:
    Clinuvel Pharmaceuticals Limited
  • Address:
    Level 6 / 15 Queen Street, 3000, Melbourne, VIC, AU

Inventor

  • Name:
    Wolgen, Philippe
  • Address:
    Melbourne, Victoria, AU

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    2006904745 P
  • Date:
    31.8.2006
  • Country:
    AU
  • Number:
    2007900862 P
  • Date:
    21.2.2007
  • Country:
    AU

Supplementary protection

Classification

  • Categories:
    A61K 38/34, A61P 17/00, A61P 17/16, A61K 8/64, A61Q 17/04, A61Q 19/00

Upload documents